×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agendas
Opening the Door to Data Transparency: What's the Verdict?
Session Chair(s)
Robert Paarlberg, MS
Principal
Paarlberg & Associates LLC, United States
This session will focus on US and EU clinical trial disclosure requirements, including results reporting and how this increase in data transparency is being perceived and used by the patient community.
Learning Objective : Identify the current US and EU requirements for disclosure of clinical trial information; Describe the differences in what is reported in ClinicalTrials.gov versus the EU Clinical Trials Register; Discuss how the increase in clinical trial data transparency is perceived and used by the patient community
Speaker(s)
Panelist
Rebecca Williams, PharmD, MPH
Essex, Part of Emmes Group, United States
Senior Clinical Trials Subject Matter Expert
Panelist
Hans-Georg Eichler, MD, MSc
Austrian Association of Social Security Bodies, Austria
Consulting Physician
Panelist
Deborah Collyar
Patient Advocates In Research (PAIR), United States
President
Have an account?
Ways to register
Registration override should work.